Use of cookies by
Norton Rose Fulbright
We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out at nortonrosefulbright.com/cookies-policy. By continuing to use this website you agree to our use of our cookies unless you have disabled them.
Norton Rose Fulbright advises bank consortium on the approval for the sale of a 59.4 per cent stake in an Italian hospital concession holder | Global law firm | Norton Rose Fulbright

Norton Rose Fulbright advises bank consortium on the approval for the sale of a 59.4 per cent stake in an Italian hospital concession holder

September 21, 2018

Contacts

Related services

Key industry sectors

Global law firm Norton Rose Fulbright has advised a group of banks, including The Royal Bank of Scotland, the European Investment Bank, Crédit Agricole CIB, UniCredit and Banca IFIS, which provided financing to Veneta Sanitaria Finanza di Progetto S.p.A., the concession holder for Ospedale dell’Angelo di Venezia-Mestre (also known as the New Hospital in Mestre), in relation to the approval for the sale of a 59.4 per cent stake in the hospital concession holder by Astaldi S.p.A. and its subsidiary Astaldi Concessioni S.p.A., to Core Infrastructure II S. à r. l., a Luxembourg company controlled by Mirova S.A., a wholly owned subsidiary of OSTRUM Asset Management Group (formerly Natixis Asset Management).

This is the second acquisition by Mirova S.A. in Italy since becoming a shareholder of Aton per il Progetto S.r.l, a project company that manages the concession for the design, construction and management of the new hospital technology centre of Udine’s Polytechnic Institute and a connected urban district heating network.

The New Hospital in Mestre, a state-of-the-art centre of healthcare excellence in Italy and Europe, with 680 beds, occupies a total surface area of 260,000 sqm and has been operational since April 2008.

The Norton Rose Fulbright team was led by partner Arturo Sferruzza, with Elisabetta Negrini (Of counsel).

For more information, see nortonrosefulbright.com/legal-notices.

Notes for editors:

Norton Rose Fulbright

Norton Rose Fulbright is a global law firm providing the world’s preeminent corporations and financial institutions with a full business law service. The firm has more than 4,000 lawyers and other legal staff based in Europe, the United States, Canada, Latin America, Asia, Australia, Africa and the Middle East.

Recognized for its industry focus, Norton Rose Fulbright is strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare. Through its global risk advisory group, the firm leverages its industry experience with its knowledge of legal, regulatory, compliance and governance issues to provide clients with practical solutions to the legal and regulatory risks facing their businesses.

Norton Rose Fulbright operates in accordance with its global business principles of quality, unity and integrity, aiming to provide the highest possible standard of legal service in each of its offices and to maintain that level of quality at every point of contact.

Norton Rose Fulbright Verein, a Swiss verein, helps coordinate the activities of Norton Rose Fulbright members but does not itself provide legal services to clients. Norton Rose Fulbright has offices in more than 50 cities worldwide, including London, Houston, New York, Toronto, Mexico City, Hong Kong, Sydney and Johannesburg. For more information, see nortonrosefulbright.com/legal-notices.